Lsv Asset Management Abbott Laboratories Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in Abbott Laboratories stock. As of the latest transaction made, Lsv Asset Management holds 4,425 shares of ABT stock, worth $512,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,425

Previous 4,400 0.57%

Holding current value

$512,857

Previous $457,000 10.28%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $2,501 - $2,953	25 Added 0.57%	4,425 $504,000
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $40,312 - $44,916	-400 Reduced 8.33%	4,400 $480,000
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $425,744 - $492,932	4,400 Added 1100.0%	4,800 $464,000
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 33.33%	400 $47,000
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $641,630 - $709,830	-5,500 Reduced 90.16%	600 $70,000
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $729,951 - $859,257	-6,900 Reduced 53.08%	6,100 $707,000
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $97,956 - $115,406	900 Added 7.44%	13,000 $1.56 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $84,000 - $91,536	-800 Reduced 6.2%	12,100 $1.32 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $76,570 - $98,000	-1,000 Reduced 7.19%	12,900 $1.18 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $518,166 - $576,840	-6,600 Reduced 32.2%	13,900 $1.21 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $793,848 - $860,778	9,700 Added 89.81%	20,500 $1.72 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $656,748 - $792,288	10,800 New	10,800 $792,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Abbott Laboratories Transaction History